L-Topaquinone | CAS#135791-48-9 | dopaquione metabolite

MedKoo Cat#: 597995 | Name: L-Topaquinone

Description:

WARNING: This product is for research use only, not for human or veterinary use.

L-Topaquinone is a metabolite of dopaquione, an important intermediate in melanogenesis.

Chemical Structure

L-Topaquinone

CAS#135791-48-9

Theoretical Analysis

MedKoo Cat#: 597995

Name: L-Topaquinone

CAS#: 135791-48-9

Chemical Formula: C9H9NO5

Exact Mass: 211.0481

Molecular Weight: 211.17

Elemental Analysis: C, 51.19; H, 4.30; N, 6.63; O, 37.88

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

L-Topaquinone; 2',4',5'-Topaquinone; L-Topaquinone residue;

IUPAC/Chemical Name

(S)-2-amino-3-(6-hydroxy-3,4-dioxocyclohexa-1,5-dien-1-yl)propanoic acid

InChi Key

YWRFBISQAMHSIX-YFKPBYRVSA-N

InChi Code

InChI=1S/C9H9NO5/c10-5(9(14)15)1-4-2-7(12)8(13)3-6(4)11/h2-3,5,11H,1,10H2,(H,14,15)/t5-/m0/s1

SMILES Code

O=C(O)[C@@H](N)CC1=CC(C(C=C1O)=O)=O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 211.17 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Cieńska M, Labus K, Lewańczuk M, Koźlecki T, Liesiene J, Bryjak J. Effective L-Tyrosine Hydroxylation by Native and Immobilized Tyrosinase. PLoS One. 2016 Oct 6;11(10):e0164213. doi: 10.1371/journal.pone.0164213. eCollection 2016. PubMed PMID: 27711193; PubMed Central PMCID: PMC5053437. 2: Ito S, Wakamatsu K. Chemistry of mixed melanogenesis--pivotal roles of dopaquinone. Photochem Photobiol. 2008 May-Jun;84(3):582-92. doi: 10.1111/j.1751-1097.2007.00238.x. Review. PubMed PMID: 18435614. 3: Rahman SF, Gobikrishnan S, Indrawan N, Park SH, Park JH, Min K, Yoo YJ, Park DH. A study on the electrochemical synthesis of L-DOPA using oxidoreductase enzymes: optimization of an electrochemical process. J Microbiol Biotechnol. 2012 Oct;22(10):1446-51. PubMed PMID: 23075798. 4: Gasowska B, Wojtasek H, Hurek J, Drag M, Nowak K, Kafarski P. Redox reaction between amino-(3,4-dihydroxyphenyl)methyl phosphonic acid and dopaquinone is responsible for the apparent inhibitory effect on tyrosinase. Eur J Biochem. 2002 Aug;269(16):4098-104. Erratum in: Eur J Biochem 2002 Oct;269(20):5101. PubMed PMID: 12180986. 5: Min K, Park DH, Yoo YJ. Electroenzymatic synthesis of l-DOPA. J Biotechnol. 2010 Mar;146(1-2):40-4. doi: 10.1016/j.jbiotec.2010.01.002. Epub 2010 Jan 18. PubMed PMID: 20083145. 6: Li YJ. Optical determination of L-tyrosine based on eggshell membrane immobilized tyrosinase. J AOAC Int. 2010 Nov-Dec;93(6):1912-5. PubMed PMID: 21313820. 7: Tsuji-Naito K, Hatani T, Okada T, Tehara T. Evidence for covalent lipoyl adduction with dopaquinone following tyrosinase-catalyzed oxidation. Biochem Biophys Res Commun. 2006 Apr 28;343(1):15-20. Epub 2006 Feb 28. PubMed PMID: 16527255. 8: Rzepka Z, Buszman E, Beberok A, Wrześniok D. From tyrosine to melanin: Signaling pathways and factors regulating melanogenesis. Postepy Hig Med Dosw (Online). 2016 Jun 30;70(0):695-708. doi: 10.5604/17322693.1208033. Review. PubMed PMID: 27356601. 9: Ling KQ, Sayre LM. A dopaquinone model that mimics the water addition step of cofactor biogenesis in copper amine oxidases. J Am Chem Soc. 2005 Apr 6;127(13):4777-84. PubMed PMID: 15796543. 10: Kahn V, Ben-Shalom N. N-acetyl-L-tyrosine (NAT) as a substrate for mushroom tyrosinase. Pigment Cell Res. 1998 Feb;11(1):24-33. PubMed PMID: 9523332. 11: Carlberg M, Jergil B, Lindbladh C, Rosengren E. Enzymatic 5-hydroxylation of L-dopa by a tyrosinase isolated from the sea anemone Metridium senile. Gen Pharmacol. 1984;15(4):301-7. PubMed PMID: 6149165. 12: Chai L, Zhou J, Feng H, Tang C, Huang Y, Qian Z. Functionalized Carbon Quantum Dots with Dopamine for Tyrosinase Activity Monitoring and Inhibitor Screening: In Vitro and Intracellular Investigation. ACS Appl Mater Interfaces. 2015 Oct 28;7(42):23564-74. doi: 10.1021/acsami.5b06711. Epub 2015 Oct 13. PubMed PMID: 26440479. 13: Moonrungsee N, Shimamura T, Kashiwagi T, Jakmunee J, Higuchi K, Ukeda H. Sequential injection spectrophotometric system for evaluation of mushroom tyrosinase-inhibitory activity. Talanta. 2012 Nov 15;101:233-9. doi: 10.1016/j.talanta.2012.09.015. Epub 2012 Sep 16. PubMed PMID: 23158317. 14: Fogal S, Carotti M, Giaretta L, Lanciai F, Nogara L, Bubacco L, Bergantino E. Human tyrosinase produced in insect cells: a landmark for the screening of new drugs addressing its activity. Mol Biotechnol. 2015 Jan;57(1):45-57. doi: 10.1007/s12033-014-9800-y. PubMed PMID: 25189462. 15: Fatibello-Filho O, da Cruz Vieira I. Flow injection spectrophotometric determination of L-Dopa and carbidopa in pharmaceutical formulations using a crude extract of sweet potato root [Ipomoea batatas (L.) Lam.] as enzymatic source. Analyst. 1997 Apr;122(4):345-50. PubMed PMID: 9177077. 16: Satooka H, Kubo I. Effects of thymol on mushroom tyrosinase-catalyzed melanin formation. J Agric Food Chem. 2011 Aug 24;59(16):8908-14. doi: 10.1021/jf2014149. Epub 2011 Aug 1. PubMed PMID: 21793504. 17: Nicklisch SC, Spahn JE, Zhou H, Gruian CM, Waite JH. Redox Capacity of an Extracellular Matrix Protein Associated with Adhesion in Mytilus californianus. Biochemistry. 2016 Apr 5;55(13):2022-30. doi: 10.1021/acs.biochem.6b00044. Epub 2016 Mar 21. PubMed PMID: 26998552; PubMed Central PMCID: PMC4934423. 18: Yamazaki Y, Kawano Y. N-(3,5-dihydroxybenzoyl)-6-hydroxytryptamine as a novel human tyrosinase inhibitor that inactivates the enzyme in cooperation with l-3,4-dihydroxyphenylalanine. Chem Pharm Bull (Tokyo). 2010 Nov;58(11):1536-40. PubMed PMID: 21048351. 19: Garcia-Molina F, Munoz-Munoz JL, Garcia-Molina M, Garcia-Ruiz PA, Tudela J, García-Cánovas F, Rodriguez-Lopez JN. Melanogenesis inhibition due to NADH. Biosci Biotechnol Biochem. 2010;74(9):1777-87. Epub 2010 Sep 7. PubMed PMID: 20834177. 20: Li WJ, Lin YC, Wu PF, Wen ZH, Liu PL, Chen CY, Wang HM. Biofunctional constituents from Liriodendron tulipifera with antioxidants and anti-melanogenic properties. Int J Mol Sci. 2013 Jan 15;14(1):1698-712. doi: 10.3390/ijms14011698. PubMed PMID: 23322020; PubMed Central PMCID: PMC3565342.